CAGR: 5%Current Market Size: USD 850 MillionFastest Growing Region: Europe
Largest Market: North AmericaProjection Time: 2022-2029Base Year: 2021
The Global Tablet Coating market is expected to grow from USD 850 million in 2021 to USD 1255.83 million by 2029, at a CAGR of 5% during the Projection period 2022-2029. The growth of this market is mainly driven owing to increasing development in the pharmaceutical sector around the world.
The coating material is placed on the tablet's surface to attain the desired qualities of the dosage form above the uncoated type. The benefits of coating include enhanced product stability, protection against the stomach environment, enhanced mechanical resistance of the dosage form, and modified release qualities. They also include better flavor, odor, and, colour of the drug and improved patient swallowing comfort. The three primary tablet coating procedures are enteric, film, and sugar. Depending on the stage of coating, different kinds of pharmaceutical coating materials are utilized in tablet coating. Binders (acacia, gelatin, cellulose derivatives), Fillers (calcium carbonate, titanium dioxide, talc), Colorants (dyes, iron oxides, titanium dioxide), and Antiadhesives are the different types of coating ingredients (talc). Coating techniques have evolved from being a form of art used in earlier times to ones that are more technologically sophisticated and tightly controlled, making it easier to comply with good manufacturing standards (GMPs). Better products have been made possible by the creation and accessibility of new coating materials, an understanding the influence of applied coatings on the subsequent release of drugs from dosage forms, and improvements in equipment design. Tablets should be examined and checked after coating. According to British Pharmacopoeia, 2009, it could be essential to remove the coating before performing a test specified in the monograph when a tablet is sold in coated forms. Where removing the coating compromises the product's functionality, it is not permitted.
Sample Request: - Global Tablet Coating Market
Market Dynamics:
Drivers:
The therapeutic efficacy and safety aspects of generic drugs are comparable to those of their branded equivalents while being less expensive. The increased use of generic medications resulted in savings for the American healthcare system of about US$ 292.6 billion in 2018. In the same year, Medicaid and Medicare saved around $90.3 billion and $468.3 billion, respectively. Given that a significant number of drugs have lost their patent protection, some countries are promoting the use of generic medications. The National Pharmaceutical Services reports that over 31 drugs lost their patent protection in 2018, and another 47 are anticipated to do so between 2019 and 2022. Critical pharmaceutical patent protection is expected to be lost for Novartis, Merck, and Eli Lilly. Between 2012 and 2021, generic erosion resulted in considerable revenue and volume losses for the branded pharmaceutical segment. During the projected period, it is anticipated that rising healthcare affordability and spending in emerging nations will increase generics sales. In the upcoming years, this is projected to propel the global tablet coatings market.
Restraints:
In comparison to traditional dosage forms, controlled drug delivery systems have a number of benefits, including increased efficacy, less toxicity, and increased patient compliance and convenience. These systems frequently utilize macromolecules as medication transporters. Recently, however, the creation of such sustained-release formulations has found extensive use for nano- and microparticles. Although many industry participants have embraced sustained-release coating technology across a range of industries, ongoing R&D is necessary to keep it competitive. The market expansion for these formulations is hampered by the high cost of R&D resources and processing technology. Sometimes it's necessary to personalize the development of microencapsulated material, and other times it must be done at an industrial size rather than a pilot scale. As a result, things now cost more to process, which eventually raises their price.
Opportunities:
One of the first industries to accept dietary supplements was the sports nutrition sector. The majority of sales in the sports nutrition market are made up of sports drinks, sports powders, and energy snacks. However, a variety of supplements have considerable demand for various administration methods. For acid-sensitive chemicals like creatine (for energy), enzymes (for digestion and inflammation), amino acids (for endurance and muscle repair), and probiotics, acid-resistant HPMC capsules are ideal (for digestive health). Variable release and flavour masking are made possible by lipid multi-particulates (LMP) technology. In the upcoming years, the market for oral formulations is projected to be driven by increased attention to sports nutrition. This is expected to drive the market for tablet coatings worldwide.
Challenges
Future trade policies may be a problem for the pharmaceutical sector, which would then affect the excipients industry, given the global changes in government policies currently underway. Trade between industrialized nations like the US and Europe, which are the leading markets in the industry, and developing nations that are regarded as pharmerging nations, like China, India, and Brazil, could be negatively impacted. Another urgent concern in this sector is BREXIT. Even though it's still unknown how Brexit will affect the pharmaceutical sector, firms like Novartis, Astra Zeneca, and Roche have already moved their manufacturing facilities to lower the risk.
Segmentation Analysis:
The global tablet coating market has been segmented based on coating type, end-use, polymer, and region.
By Coating Type
The coating type segment is film-coated, sugar-coated, and enteric-coated. The film-coated segment led the tablet coating market with a market share of around 39% in 2021. By utilizing hues and colors for identification, these coatings significantly reduce the possibility of pharmaceutical errors. Additionally, they increase patient compliance through attractiveness, which further helps market expansion.
By End-use
The end-use includes pharmaceutical and nutraceutical. The pharmaceutical segment led the tablet coating market with a market share of around 60% in 2021. The rise in the number of illnesses for which tablet-based formulations are the main treatment is a major factor in the pharmaceutical industry's demand for tablet coatings. The pharmaceutical industry's market for tablet coatings is expanding as a result of the increased need for creative drug delivery formulations.
By Polymer
The polymer includes vinyl, acrylic, and cellulose. The cellulose segment led the tablet coating market with a market share of around 40% in 2021. The high adoption of these polymers, which can be formed into coatings with generally acceptable properties (like good film strength, aqueous solubility, and compressibility), less sensitivity to wet granulation, flowability, and better tableting at a low cost, can be attributed to the large share of this market. The acceptance of these polymers by international regulatory bodies and their ready availability from a variety of vendors are further factors influencing their use in coating applications.
By Regional Analysis:
The regions analyzed for the Tablet Coating market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region dominated the tablet coating market and held a 35% share of the market revenue in 2021.
Global Tablet Coating Market- Country Analysis:
Germany's tablet coating market size was valued at USD 90 million in 2021 and is expected to reach USD 123.17 million by 2029, at a CAGR of 4% from 2022 to 2029. The market in China is anticipated to experience rapid growth during the Projection period due to favorable government regulations, an increase in the number of companies establishing manufacturing facilities there, an increase in the outsourcing of drug production to specialized contract manufacturing organizations (CMOS), and low labor and manufacturing costs.
China tablet coating market size was valued at USD 76.88 million in 2021 and is expected to reach USD 101.23 million by 2029, at a CAGR of 3.5% from 2022 to 2029. The market in China is growing at a rapid pace as the increase in outsourcing of drug manufacturing to specialized contract manufacturing organizations (CMOS), the rise in the number of companies setting up manufacturing units in the country, favorable government regulations, and low labor & manufacturing costs are projected to drive the market in China during the Projection period.
India's tablet coating market size was valued at USD 66.64 million in 2021 and is expected to reach USD 84.41 million by 2029, at a CAGR of 3% from 2022 to 2029. The country's market is driven by the rising trend toward generic drugs and supportive governmental measures for generic drug manufacturers. Regional growth is also fueled by rising consumer health consciousness and the widespread use of nutraceutical products.
Key Industry Players Analysis:
To increase their market position in the global tablet coating business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.
Latest Development:
Report Metrics
Report Attribute |
Details |
Study Period |
2021-2029 |
Base year |
2021 |
CAGR (%) |
850% |
Market Size |
5 million in 2021 |
Projection period |
2022-2029 |
Projection unit |
Value (USD) |
Segments covered |
By Coating Type, By End-Use, By Polymer, and Region. |
Report Scope |
Revenue Projection, competitive landscape, company ranking, growth factors, and trends |
Companies covered |
Merck KGaA, Wincoat Colours and Coatings Pvt. Ltd., DuPont, BASF Corporation, BPSI Holdings LLC (Colorcon), Corel Pharma Chem., Eastman Chemical Company, Evonik Industries AG, Roquette Freres, Sensient Technologies Corporation, Kerry, JRS Pharma., among others |
By Coating Type |
|
By End-Use |
|
By Polymer |
|
Regional scope |
|
Scope of the Report
Global Tablet Coating Market by Coating Type:
Global Tablet Coating Market by End-use:
Global Tablet Coating Market by Polymer:
Global Tablet Coating Market by Region:
Global Tablet Coating market size was USD 850 million in 2021.
Global Tablet Coating market will grow at a CAGR of 5% during the Projection period 2022-2029
Advancement in pharmaceutical industries around the globe is projected to influence the market in the Projection years.
United States, Germany, China, India, and United Kingdom.
High cost of microencapsulation is primarily impeding the growth of the Tablet Coating market.
Political Factors- Before going on the market, all new medications, both brand-new and generic, must have regulatory authority approval. The product Life Cycle Assessment (LCA) is typically taken into account in this procedure when it comes to CP elements. Even though LCA has been used in some industrial sectors as an environmental management tool since the 1970s and underwent significant methodological development in the 1990s, especially for applications in process selection, design, and optimization (Azapagic, 1999), as well as more recently in production logistics (Burchart-Korol, 2011a), very few LCA studies pertaining to pharmaceutical products or processes can be found in the literature at this time.
Economical Factors- With China being the largest generic medicine market in Asia and the second largest in the world after the US, rising healthcare expenses have led to an increase in the use of generic medications. The bulk of pharmaceuticals sold in China are domestically produced generics, which are preferred by less fortunate patients over more expensive branded medications. The increasing sale of generic medicines also increases the need for tablet coating providing the growth to the market. Since people in developing nations like China, where there is still no integrated evaluation for integrating CP technologies in the pharmaceutical business, face resource and environmental issues, cleaner production (CP) in particular is helpful. This increases the need for more robust and high investment in the pharmaceutical industry.
Social Factor- The new approach to addressing the real costs of adopting cleaner technologies, which are primarily related to regulatory issues in the pharmaceutical industry, aims to promote cultural change as well as be used in the decision-making process for other pharmaceutical facilities still using organic solvents based coatings in the production of tablets. Given the extent of the global generic medicine market, the importance of small-scale operations is further highlighted. Market players operating in the tablet coatings market look for the products which is socially accepted for the coating purpose as it must not harm the sentiments of the humans or mankind. A study is presented to encourage proactive action in this area toward totally removing the use of organic solvents from film-coating systems in the manufacture of pharmaceutical solid dosage forms.
Technological Factors- There are a number of articles here that address the challenges of promoting technological advancements to improve environmental preservation and reduce pollutant emissions at the source, as well as the function of regulations as promoters of clean technology, particularly for the reduction of VOC emissions (Belis-Bergouignan et al., 2004). In terms of pharmaceutical industry production processes, "end of pipe" (EOP) technologies or reduced consumption of toxic and hazardous raw materials/reduction of emissions and wastes from the process itself may be applied. This is because the pharmaceutical industry is one of the largest users of organic solvents in terms of the amount of the final product (Slater et al., 2006).
Environmental Factors- Despite the requirement for organic solvent-based coating in the pharmaceutical industry, these coatings are severely constrained by potential solvent toxicity, flammability, and environmental safety concerns. It is challenging to entirely expel organic solvent vapours from the coating chamber, even with a suitable ventilation system, raising the danger of toxicity and explosion. Costs of production may rise as a result of environmental and regulatory concerns. A common film coating technique in modern pharmaceutical practise is aqueous coating. Compared to organic solvent-based coatings, it has several benefits in terms of operator safety, environmental pollution, and explosion danger.
Legal Factors- It is crucial to fully understand the rules and legal characteristics of a country with regard to its industry and particular company operations when developing a firm in a new country or region. Our team of legal specialists is capable of precisely evaluating the legal aspects that could either directly or indirectly affect your company. The ready-to-use coatings VIVACOAT free, without titanium dioxide, were introduced by JRS PHARMA. The TiO2-free coating solution offered by VIVACOAT free is perfect for both pharmaceutical and nutraceutical compositions. For the market for dietary supplements and nutritional products, Colorcon introduced its newest mineral-free addition to the label-friendly "Nutrafinish P" Film Coatings.
List of Table
List of Figures